CDIO Relative Valuation
CDIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, CDIO is overvalued; if below, it's undervalued.
Historical Valuation
Cardio Diagnostics Holdings Inc (CDIO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 9.88 is considered Undervalued compared with the five-year average of -3.95. The fair price of Cardio Diagnostics Holdings Inc (CDIO) is between 99.92 to 110.84 according to relative valuation methord. Compared to the current price of 2.96 USD , Cardio Diagnostics Holdings Inc is Undervalued By 97.04%.
Relative Value
Fair Zone
99.92-110.84
Current Price：2.96
97.04%
Undervalued
-0.41
PE
1Y
3Y
5Y
0.00
EV/EBITDA
Cardio Diagnostics Holdings Inc. (CDIO) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.
0.12
EV/EBIT
Cardio Diagnostics Holdings Inc. (CDIO) has a current EV/EBIT of 0.12. The 5-year average EV/EBIT is -1.89. The thresholds are as follows: Strongly Undervalued below -5.77, Undervalued between -5.77 and -3.83, Fairly Valued between 0.05 and -3.83, Overvalued between 0.05 and 2.00, and Strongly Overvalued above 2.00. The current Forward EV/EBIT of 0.12 falls within the Overvalued range.
9.88
PS
Cardio Diagnostics Holdings Inc. (CDIO) has a current PS of 9.88. The 5-year average PS is 89.64. The thresholds are as follows: Strongly Undervalued below -277.33, Undervalued between -277.33 and -93.84, Fairly Valued between 273.12 and -93.84, Overvalued between 273.12 and 456.60, and Strongly Overvalued above 456.60. The current Forward PS of 9.88 falls within the Historic Trend Line -Fairly Valued range.
-1.11
P/OCF
Cardio Diagnostics Holdings Inc. (CDIO) has a current P/OCF of -1.11. The 5-year average P/OCF is -3.07. The thresholds are as follows: Strongly Undervalued below -7.93, Undervalued between -7.93 and -5.50, Fairly Valued between -0.64 and -5.50, Overvalued between -0.64 and 1.79, and Strongly Overvalued above 1.79. The current Forward P/OCF of -1.11 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
Cardio Diagnostics Holdings Inc. (CDIO) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.
Cardio Diagnostics Holdings Inc (CDIO) has a current Price-to-Book (P/B) ratio of 0.62. Compared to its 3-year average P/B ratio of 4.40 , the current P/B ratio is approximately -86.02% higher. Relative to its 5-year average P/B ratio of 4.73, the current P/B ratio is about -86.99% higher. Cardio Diagnostics Holdings Inc (CDIO) has a Forward Free Cash Flow (FCF) yield of approximately -114.70%. Compared to its 3-year average FCF yield of -58.43%, the current FCF yield is approximately 96.32% lower. Relative to its 5-year average FCF yield of -55.75% , the current FCF yield is about 105.72% lower.
0.62
P/B
Median3y
4.40
Median5y
4.73
-114.70
FCF Yield
Median3y
-58.43
Median5y
-55.75
Competitors Valuation Multiple
The average P/S ratio for CDIO's competitors is 1436.13, providing a benchmark for relative valuation. Cardio Diagnostics Holdings Inc Corp (CDIO) exhibits a P/S ratio of 9.88, which is -99.31% above the industry average. Given its robust revenue growth of -56.61%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of CDIO decreased by 77.58% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -21.47K to -60.05K.
The secondary factor is the Revenue Growth, contributed -56.61%to the performance.
Overall, the performance of CDIO in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
RAY
Raytech Holding Ltd
2.13USD
0.00%
STEC
Santech Holdings Ltd
1.53USD
37.25%
YI
111 Inc
2.86USD
0.00%
MSS
Maison Solutions Inc
0.32USD
3.22%
EVTV
Envirotech Vehicles Inc
0.5123USD
-10.79%
ZKIN
ZK International Group Co Ltd
1.56USD
0.00%
MOGU
Mogu Inc
2.19USD
0.92%
PSHG
Performance Shipping Inc
2.16USD
0.00%
MOB
Mobilicom Ltd
7.6USD
3.26%
Frequently Asked Questions
Is Cardio Diagnostics Holdings Inc (CDIO) currently overvalued or undervalued?
Cardio Diagnostics Holdings Inc (CDIO) is now in the Undervalued zone, suggesting that its current forward PS ratio of 9.88 is considered Undervalued compared with the five-year average of -3.95. The fair price of Cardio Diagnostics Holdings Inc (CDIO) is between 99.92 to 110.84 according to relative valuation methord. Compared to the current price of 2.96 USD , Cardio Diagnostics Holdings Inc is Undervalued By 97.04% .
What is Cardio Diagnostics Holdings Inc (CDIO) fair value?
CDIO's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of Cardio Diagnostics Holdings Inc (CDIO) is between 99.92 to 110.84 according to relative valuation methord.
How does CDIO's valuation metrics compare to the industry average?
The average P/S ratio for CDIO's competitors is 1436.13, providing a benchmark for relative valuation. Cardio Diagnostics Holdings Inc Corp (CDIO) exhibits a P/S ratio of 9.88, which is -99.31% above the industry average. Given its robust revenue growth of -56.61%, this premium appears unsustainable.
What is the current P/B ratio for Cardio Diagnostics Holdings Inc (CDIO) as of Jan 07 2026?
As of Jan 07 2026, Cardio Diagnostics Holdings Inc (CDIO) has a P/B ratio of 0.62. This indicates that the market values CDIO at 0.62 times its book value.
What is the current FCF Yield for Cardio Diagnostics Holdings Inc (CDIO) as of Jan 07 2026?
As of Jan 07 2026, Cardio Diagnostics Holdings Inc (CDIO) has a FCF Yield of -114.70%. This means that for every dollar of Cardio Diagnostics Holdings Inc’s market capitalization, the company generates -114.70 cents in free cash flow.
What is the current Forward P/E ratio for Cardio Diagnostics Holdings Inc (CDIO) as of Jan 07 2026?
As of Jan 07 2026, Cardio Diagnostics Holdings Inc (CDIO) has a Forward P/E ratio of -0.41. This means the market is willing to pay $-0.41 for every dollar of Cardio Diagnostics Holdings Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for Cardio Diagnostics Holdings Inc (CDIO) as of Jan 07 2026?
As of Jan 07 2026, Cardio Diagnostics Holdings Inc (CDIO) has a Forward P/S ratio of 9.88. This means the market is valuing CDIO at $9.88 for every dollar of expected revenue over the next 12 months.